Sutro Biopharma Non-Current Deferred Revenue (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

10.63 -0.70 (-6.18%) USD | NASDAQ | Jan 13, 16:00

11.26 +0.63 (+5.93%) After-Hours: 07:07

View Non-Current Deferred Revenue (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Daré Bioscience, Inc.	Upgrade
Syndax Pharmaceuticals, Inc.	--
Crinetics Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	--